Sun Pharma To Buy Ranbaxy!

• Sun pharmaceutical industries limited acquired ranbaxy laboratories limited in an all-share deal with total equity value of $3.2 billion.
• Earlier in 2008, daiichi sankyo had bought ranbaxy laboratories for $4.6 billion.In The combined entity, promoters of sun pharma will hold close to 56% while daiichi sankyo will hold 9% stake.
• Sun pharma has strong presence in us markets while ranbaxy has strong presence in emerging markets and rest of world markets.
• In india the sun pharma is strong on chronic side while ranbaxy is strong on acute side.
• Sun pharmaceutical industries is an indian multinational pharmaceutical company that sells pharmaceutical formulations and active pharmaceutical ingredients (apis) primarily in india and us, this company started by dilip shanghvi.ranbaxy laborataries limited is an indian multinational pharmaceutical company that was started by ranbir singh and gurbax singh.